They observed that KLF14‐AAV mice gained less weight, had greater expression of browning genes, had decreased markers of hepatic steatosis, had improved glycemic tolerances, and had smaller adipocytes (Mao et al., 2023). The gene discussed is KLF14; the disease is fatty liver disease.